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Abstract 
Background: Plasmodium ovale, considered the rarest of the malaria parasites of humans, consists of two morpho‑
logically identical but genetically distinct sympatric species, Plasmodium ovale curtisi and Plasmodium ovale wallikeri. 
These parasites resemble morphologically to Plasmodium vivax with which they also share a tertian periodicity and 
the ability to cause relapses, making them easily misidentified as P. vivax. Plasmodium ovale infections are rarely 
reported, but given the likelihood of misidentification, their prevalence might be underestimated.
Methods: Morphological and molecular analysis of confirmed malaria cases admitted in Singapore in 2012–2014 
detected nine imported P. ovale cases that had been misidentified as P. vivax. Since P. ovale had not been previously 
officially reported in Singapore, a retrospective analysis of available, frozen, archival blood samples was performed and 
returned two additional misidentified P. ovale cases in 2003 and 2006. These eleven P. ovale samples were character‑
ized with respect to seven molecular markers (ssrRNA, Potra, Porbp2, Pog3p, dhfr‑ts, cytb, cox1) used in recent studies to 
distinguish between the two sympatric species, and to a further three genes (tufa, clpC and asl).
Results: The morphological features of P. ovale and the differential diagnosis with P. vivax were reviewed and illus‑
trated by microphotographs. The genetic dimorphism between P. ovale curtisi and P. ovale wallikeri was assessed by 
ten molecular markers distributed across the three genomes of the parasite (Genbank KP050361‑KP050470). The data 
obtained for seven of these markers were compared with those published and confirmed that both P. ovale species 
were present. This dimorphism was also confirmed for the first time on: (1) two genes from the apicoplast genome 
(tufA and clpC genes); and, (2) the asl gene that was used for phylogenetic analyses of other Plasmodium species, and 
that was found to harbour the highest number of dimorphic loci between the two P. ovale species.
Conclusion: Misidentified P. ovale infections are reported for the first time among imported malaria cases in Singa‑
pore. Genetic dimorphism between P. ovale curtisi and P. ovale wallikeri was confirmed using markers from the para‑
sites’ three genomes. The apparent increase of imported P. ovale since 2012 (with yearly detection of cases) is puz‑
zling. Given decrease in the overall number of malaria cases recorded in Singapore since 2010 the ‘resurgence’ of this 
neglected species raises public health concerns.
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Background
The formal description of Plasmodium ovale by Ste-
phens in 1922 [1] was made more than 30 years after that 
of the other three species that naturally infect humans. 
However, its morphological resemblance to Plasmo-
dium vivax delayed its acceptance as a bona fide species 
by many years [2, 3]. The clinical symptoms of primary 
P. ovale infections are typical of malarial infections (ter-
tian high fever, chills, aches, and rigours) and the disease 
rarely progresses to severity although at least one fatal 
case was reported recently [4]. Peak parasitaemia is rela-
tively low, and the infection often self-resolves, but with 
a tendency to re-appear even after effective treatment 
with schizontocidal drugs, as this species shares with P. 
vivax the ability to generate hypnozoites, dormant liver 
stages that activate weeks or months later and lead to a 
relapse episode [5]. Given the rarity of clinical severity, P. 
ovale has been used in malariotherapy for the treatment 
of neurosyphilis from 1930 to the 1960s [5–8], thereby 
providing data on the natural course of infection and the 
acquisition of immunity.
Plasmodium ovale occurs principally in West Africa 
and the Southwest Pacific where it can account for more 
than 10 % of all malaria infections. Outside these regions, 
its prevalence is generally quite low (<5  %, and often it 
is very rarely encountered), and its presence is yet to 
be confirmed in the Americas [9–16]. However, results 
from surveys based on sensitive molecular detection 
assays indicate that routine light microscopic examina-
tion of blood smears has underestimated its true preva-
lence [17–20]. In the course of such molecular surveys, 
a dimorphism in the 18S small sub-unit ribosomal RNA 
(ssrRNA) genes was discovered, and the otherwise mor-
phologically similar P. ovale parasites were divided into 
‘classical’ and ‘variant’ types [21, 22]. The dimorphism 
was later found to extend to other P. ovale genes, which 
led to the proposal that P. ovale is actually a species com-
plex comprising two sympatric species: Plasmodium 
ovale curtisi (classic type) and Plasmodium ovale wal-
likeri (variant type) [23]. These two parasites have been 
observed in diverse endemic areas [24, 25], and the pres-
ence of a variant type was reported in a chimpanzee from 
Cameroon [26].
Singapore was officially declared free from malaria in 
November 1982 [27] after an assiduous anti-malarial 
programme initiated in 1911, which was only disrupted 
during World War II [28–30]. Nevertheless, Singapore 
remains highly vulnerable to the re-emergence of malaria 
due to the natural presence of competent vectors and 
the large number of foreigners arriving from malaria-
endemic countries. Thus, 29 outbreaks of malaria have 
been reported in Singapore between 1983 and 2007 [31] 
and a focus of autochthonous transmissions of P. vivax 
confirmed in 2009 [32]. Furthermore, rare local zoonotic 
transmission of Plasmodium knowlesi has been recorded 
[33–35]. Surveillance and epidemiological monitoring 
of malaria cases are managed by the Ministry of Health 
(MOH) in close collaboration with the National Envi-
ronmental Agency (NEA) which implements measures 
to control vector populations. The Malaria Reference 
Centre (MRC) relocated from the National University of 
Singapore (NUS) to the National Public Health Labora-
tory (NPHL) in 2010, along with the clinical malaria noti-
fication reports and their related blood smears collection 
(1994–2008), 226 frozen blood samples (collected from 
2001 to 2008), and the submitted clinical malaria-posi-
tive samples from 2009. Since 2010, all notified malaria-
positive clinical samples are sent directly to MRC-NPHL 
where a systematic species confirmation of all malaria-
positive cases notified in Singapore is carried out both by 
classical morphology [36–38] and by a polymerase chain 
reaction (PCR) assay [39]. These data contribute to the 
malaria surveillance programme that aims to validate the 
routine morphological testing performed by the clinical 
laboratories, and to monitor any outbreaks or cases of re-
introduction of malaria in Singapore.
Cases of P. ovale have never been officially reported in 
Singapore (Pr. Goh KT, pers. comm.), but examination of 
the reports from the country’s clinical laboratories from 
1994 to 2014 revealed two cases: (1) a suspected P. ovale 
infection mixed with Plasmodium falciparum in 1998, 
although the morphological examination by the MRC 
was inconclusive at that time; and, (2) a suspected P. ovale 
infection in 2013 that was later confirmed to be P. vivax 
by MRC-NPHL. This report presents evidence of recently 
imported P. ovale infections in Singapore that had been 
misidentified as P. vivax, and includes a description of 
morphological and molecular characteristics of these 
parasites.
Methods
Samples from malaria‑positive cases, Singapore (2001–
2014)
From 2001 to 2014, a total of 2158 positive malaria cases, 
mainly imported, were notified to MOH by the clinical 
laboratories. For the period 2009–2014, a total of 830 
positive malaria cases were directly received in MRC-
NPHL and the infecting species was confirmed for all by 
morphology and by molecular methods. For the earlier 
period 2001–2008, archived frozen blood samples were 
available for 226 cases, and these were retrospectively 
tested as above. Thus, a total of 1,056 positive malaria 
cases recorded in Singapore were included in the pre-
sent study. All the samples were collected for surveillance 
purpose for the MOH under the Infectious Diseases Act 
(Chapter 137), Part III-Control of Infectious Diseases 
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within Singapore, section  7–Public Health Surveillance 
Programmes.
Blood smears for microscopy
For routine surveillance, thick and thin blood films 
were prepared using standard procedures. Briefly, for 
thin smears one drop of blood was spread to a mon-
olayer onto a glass slide using the edge of another glass 
slide, quickly air dried, fixed with absolute methanol 
and stained 20  min by 10  % Giemsa stain (Merck, Sin-
gapore) in pH =  7.2 phosphate buffer; for thick smears 
one drop of blood was smeared onto a glass slide, slowly 
and fully dried at room temperature or in an incubator, 
de-haemoglobinized in water and stained 8 min by 10 % 
Giemsa stain (Merck, Singapore) in pH = 7.2 phosphate 
buffer. Then all the smears were protected by a cover 
slip mounted with Eukitt ® (Sigma-Aldrich, Singapore) 
mounting medium and dried before reading. Blood 
smears were examined under ×1000 magnification with 
an Olympus CX31 microscope (Olympus, Singapore) 
and microphotographs taken with a Nikon Eclipse 80i 
microscope equipped with a Nikon DS Ri1 camera and 
the Nikon NIS Elements D Imaging Software (Nikon, 
Singapore).
Blood DNA extraction
For routine surveillance, DNA was extracted using the 
EZ1® Advanced XL and the EZ1® DNA Blood 200 µL Kit 
(Qiagen®, Singapore) from 200 µL whole blood collected 
on EDTA following the manufacturers’ recommenda-
tions. The DNA template obtained was eluted in 200 µL 
stored at −30 °C until use.
Identification of Plasmodium species by PCR
The protocol for routine surveillance includes two con-
secutive steps: first, a fast real-time PCR (rt-PCR) screen 
for the presence of malaria parasites by targeting a 186 bp 
fragment of the ssrRNA genes. The reactions are car-
ried out using the StepOne™Plus Real-Time PCR System 
(Applied Biosystems®, Singapore), each in a final volume 
of 20 µL containing 10 µL of QuantiFast™ Probe master 
mix (Qiagen®, Singapore), 0.4 µM of each primer, 0.2 µM 
of each probe, 4  µL of nuclease free water, and 4  µL of 
DNA template, as previously described [40]. Samples 
found positive were then subjected to published nested-
PCR (nt-PCR) assays that allow determination of the spe-
cies, including P. knowlesi [39, 41]. All the reactions were 
run on Veriti® Thermal Cycler (Applied Biosystems®, 
Singapore) following the cycling conditions described in 
[39, 41] and PCR products were visualized after electro-
phoresis using the QIAxcel® Advanced instrument (Qia-
gen®, Singapore).
Genetic characterization of Plasmodium ovale
In order to analyse genetic diversity, defined regions from 
ten different genes were amplified and then sequenced 
from all confirmed P. ovale-infected samples. All ampli-
fication reactions were run on Veriti® Thermal Cycler 
(Applied Biosystems®, Singapore) and PCR products 
were visualized after electrophoresis using the QIAx-
cel® Advanced instrument (Qiagen®, Singapore). The 
PCR products form all the assays were purified using the 
QIAquick® PCR Purification Kit (Qiagen®, Singapore) 
following manufacturers’ recommendations, eluted in 
30  µL of nuclease free H2O and stored at −30  °C until 
use.
In order to achieve a fuller characterization of the P. 
ovale samples, genes belonging to the three genomes of 
the parasite were amplified and sequenced: (1) fragments 
of five nuclear genes that had been used previously to 
characterize the two P. ovale species: the 18S small sub-
unit ribosomal RNA gene (ssrRNA), the reticulocyte 
binding protein 2 gene (Porbp2), the glyceraldehyde-
3-phosphatase gene (Pog3p), the tryptophan rich antigen 
gene (Potra), and the dihydrofolate reductase thymidylate 
synthase gene (dhfr-ts), as well as a gene used for evolu-
tionary studies of Plasmodium that had not been previ-
ously characterized for P. ovale, the adenylosuccinate 
lyase gene (asl); (2) fragments of two conserved genes 
from the mitochondrial genome commonly used for phy-
logenetic and evolution studies: the cytochrome c oxi-
dase 1 gene (cox1) and the cytochrome b gene (cytb) were 
amplified and sequenced; and, (3) fragments of two con-
served genes present on the apicoplast genome used for 
evolution studies that had not been previously character-
ized for P. ovale: the elongation factor Tu gene (tufA) and 
the caseinolytic protease C gene (clpC).
ssrRNA fragments were obtained through a nested PCR 
assay [39] with the primary amplification carried out 
with the rPLU1 + rPLU5 primer pair and the secondary 
reaction with the rPLU3 + rPLU2 primer pair, leading to 
the amplification of a fragment of about 862 bp [23, 25]. 
Porbp2, Potra and Pog3p fragments were obtained via a 
single PCR amplification as previously described [23] 
to yield fragments of 793 bp for Porbp2, from 293 bp to 
365 bp for Potra, and 662 bp for Pog3p.
dhfr-ts fragments were obtained via a nested PCR 
amplification using a modified protocol based on previ-
ously published methods [23, 42]. The primary reaction is 
performed with one set of pan-Plasmodium primers (Pla-
dhfrF–Pla-dhfrR) to yield a fragment of about 1925  bp, 
which was used as a template for secondary semi-nested 
amplifications performed with one of the primers used 
in the first amplification, paired with one P. ovale-spe-
cific oligonucleotide primers (Pla-dhfrF  +  Po5gsp2 and 
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Po3gsp1 + Pla-dhfrR) to yield two overlapping fragments 
of about 870 bp and 1160 bp, respectively. Both products 
were sequenced to obtain the full dhfr-ts gene.
asl fragments were obtained with a newly devel-
oped single PCR amplification using one set of 
pan-Plasmodium oligonucleotide primers:  asl-F 
(5′-CCMATCGAYGGGMGRTACAAA-3′) and asl-R 
(5′-TGTAAATTHCCYTCWGCATTTTC-3′) to obtain 
a fragment of about 915  bp. This amplification reaction 
is carried out in a total volume of 20  µL containing 1X 
High Fidelity PCR Buffer, 3 mM of MgSO4, 0.5 U of Plati-
num® Taq DNA Polymerase High Fidelity (Invitrogen™, 
Singapore), 0.2 mM of each dNTP (Promega, Singapore), 
0.25 µM of each primer and 1.5 µL of the original DNA 
template. After an initial denaturation at 95 °C for 3 min, 
the cycling conditions were 94 °C for 30 s, 53 °C for 1 min 
and 68 °C for 1 min followed by a final extension at 68 °C 
for 10 min.
cox1 fragments were obtained using a nested PCR pro-
tocol as previously described [26], to yield a fragment 
of about 1412  bp. Cytb fragments were obtained using 
a nested PCR protocol as previously described [43], to 
yield a fragment of about 1175 bp.
tufa fragments were obtained using a nested PCR pro-
tocol as previously described [44], to yield a fragment of 
about 814 bp. clpC fragments were obtained using a sin-
gle PCR amplification as previously described [44], to 
yield a fragment of about 647 bp.
Sequencing
The purified PCR products were sequenced in both direc-
tion using the BigDye® Terminator v3.1 cycle sequencing 
Kit (Applied Biosystems®, Singapore) using the appro-
priate oligonucleotide primers, following manufacturers’ 
recommendations. Then the BigDye® reaction’s prod-
ucts were purified using the BigDye® XTerminator™ 
Purification Kit (Applied Biosystems®, Singapore) fol-
lowing manufacturers’ recommendations before being 
sequenced on a 3500 × l Genetic Analyzer (Applied Bio-
systems®, Singapore).
Sequences analysis
Alignment and cross-checking of the sequences were 
performed with CLC Main Workbench 5.7 software 
(CLC bio–Qiagen®, Singapore. Multiple alignments of 
the sequences with published sequences from GenBank 
were created to study the polymorphism between the two 
P. ovale species at key loci for each gene.
Phylogenetic analyses
Molecular phylogenies were derived from a ≈800  bp 
fragment of the asl gene by maximum likelihood (ML) 
method with GTR + I +Γ model using PhyML software 
and by neighbour joining (NJ) method with J-C model 
using BioNJ algorithm. Nodal robustness of the tree 
was evaluated by non-parametric bootstrapping (1000 
replicates).
Results
Detection of imported Plasmodium ovale cases 
in Singapore
Among the 316 cases notified to MOH by the clinical lab-
oratories for the 2012–2014 period, nine cases reported 
as P. vivax have been re-identified as P. ovale by the 
MRC-NPHL (2012 n = 4, 2013 n = 3 and 2014 n = 2). 
As a consequence of these misidentifications, the MRC-
NPHL conducted a retrospective study using the same 
combined morphological and molecular approaches on 
the 226 available malaria-positive, frozen blood sam-
ples collected between 2001 and 2008 in Singapore, and 
on samples from all the cases (n = 511) recorded during 
2009–2011. This test returned a further two P. ovale-pos-
itive cases, one in 2003 and one in 2006, both misdiag-
nosed as P. vivax. Details of the reports and case histories 
for all known P. ovale cases in Singapore are presented in 
Additional file  1. To date, a single mixed infection case 
(not reconfirmed) and 11 pure infection P. ovale cases 
have been identified in Singapore.
Morphological diagnosis
All the confirmed P. ovale cases in Singapore have been 
misidentified as P. vivax by the routine morphologi-
cal examination performed at the hospital laboratories 
(Additional file 1). Thus, it seems important and useful to 
include a description of the erythrocytic stages based on 
[1, 7, 9, 45].
Description
The merozoite of P. ovale preferentially invades a reticu-
locyte, hence most of the young stages of this parasite are 
found in young red blood cells (RBCs).
Ring (Fig. 1a–c)
The youngest ring stages have a prominent round nucleus 
(Fig.  1a–c) that is often detached from the wisp of the 
cytoplasm, with a central vacuole (Fig. 1b, c). As this early 
stage progresses, the infected RBC becomes enlarged. 
Sometimes, the outline of the infected RBC changes to a 
slightly oval shape. Fimbriation may occur and the stip-
pling starts to appear (Fig.  1a–c). The amount of cyto-
plasm increases as the parasite develops.
Trophozoite (Fig. 1d–g)
In the young trophozoite, the vacuole reduces in size and 
tends to disappear later. The cytoplasm becomes more 
abundant (Fig.  1d–f) and could appear as ‘pulled out’ 
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or ragged (Fig.  1g). Sometimes it is possible to observe 
unusual elongated trophozoites that resemble the band 
form of Plasmodium malariae. The stippling (known 
as Schüffner stippling) increases and covers the whole 
infected RBC (Fig. 1f, g), which may begin to appear really 
oval in shape (Fig. 1d, f ) with fimbriated edges (Fig. 1f ). 
At the same time the pigment appears as a fine dust, like 
brown grains (Fig. 1f ). As the parasite grows, these grains 
aggregate in dark brown beads (Fig. 1g) and occasionally 
appear greenish as light is reflected off them. In the late 
trophozoite, the nucleus and the cytoplasm increases sig-
nificantly in size (Fig. 1g) and the parasite may occupy up 
to half of the RBC. The typical schüffnerization progresses 
to larger and larger but regular red/violet dots that some-
time obscure the infected RBC (Fig. 1f, g).
Schizont (Fig. 1h–m)
The prominent nucleus that appears as a deep red-stain-
ing mass in a lighter matrix starts to divide into nuclei 
that remain noticeably large (Fig.  1h). At this time the 
markedly blue-staining cytoplasm of the trophozoite 
can fade (Fig.  1f ) before turning more purplish-blue in 
the late stages (Fig. 1i–l). The chromatin in the growing 
schizont is at first condensed (Fig.  1i) before it divides 
(Fig. 1j, k) to produce about eight nuclei (Fig. 1l). At the 
same time, the pigment grains continue to come together, 
although with no special localization within the infected 
RBC (Fig.  1i–k), and tend to form a single yellowish-
brown patch (Fig.  1m). The Schüffner dots are more 
abundant and may darken the infected RBC (Fig.  1k, 
l). At maturity (Fig.  1m), typically eight merozoites are 
formed (range from 4 to 16). Higher numbers of mero-
zoites occur more often in patients that relapse and have 
chronic infection; they are less neatly arranged (Fig.  1l) 
compared to those observed in a P. malariae schizont.
Gametocytes (Fig. 1n–r)
These usually appear late during the infection. The young 
gametocyte is difficult to distinguish from the compact 
late trophozoite, but generally the pigment is coarser 
and darker (Fig. 1n). As growth proceeds the gametocyte 
increases in size to fill the infected RBC completely. The 
changes to the infected RBC induced by the gametocytes 
are similar to those described for the asexual stages. The 
Fig. 1 Microphotographs of Plasmodium ovale in Giemsa‑stained thin blood films collected in Singapore. a–c ring stages, d, e young trophozoites, f 
trophozoite, g late trophozoite, h young schizont, i–k growing schizont, l late schizont, m ruptured schizont, n young gametocyte, o, p developing 
macrogametocytes, q macrogametocyte, r microgametocyte. a–e, h–m, o, q and r are P. ovale curtisi while f, g, n and p are P. ovale wallikeri
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macrogametocyte has a medium blue-stained cytoplasm, 
the nucleus is large, compact and eccentrically located, 
with a non-homogenous distribution of dark red and 
light red staining, and generally adopts a semi-lunar to 
oval shape (Fig. 1o–q). The stippling of this stage is usu-
ally prominent (Fig. 1o–q), stains red, and is more or less 
organized in a ring around the parasite. The cytoplasm of 
the microgametocyte is pinker (Fig. 1r), with a very large 
nucleus that can occupy almost half of the parasite con-
sists of areas that are stained a darker red, surrounded 
by a diffuse area of chromatin that fades to pale pink 
(Fig.  1r). Obvious and deep red-staining Schüffner dots 
encircle the parasite. The dark brown or black granules of 
pigment in the gametocyte are scattered throughout the 
cytoplasm (Fig.  1p, q), but occasionally in macrogame-
tocytes they have a tendency to come together in a rod 
shape (Fig. 1p).
Differential diagnostic
In Giemsa-stained thin blood smears of the malaria 
parasite species usually found in humans (P. falciparum, 
P. vivax, P. malariae, P. ovale, and P. knowlesi), P. ovale 
could only be morphologically confused with P. vivax, 
the other tertian human malaria parasite that produces 
hypnozoite stages capable of inducing a relapse. In order 
to emphasize the differential diagnostic for P. ovale and 
P. vivax, comparative microphotographs of P. vivax are 
furnished in Fig. 2a–r. Additional details can be found in 
the comparison between the Donaldson strain of P. ovale 
with two strains of P. vivax [46].
In P. ovale infections, the infected RBCs are usually 
normal or just slightly enlarged (up to 1.25×), while 
those infected with P. vivax (Fig. 2a–r) are usually more 
enlarged (1.5× to up to 2×). The change in the shape of 
the infected RBC is another characteristic of P. ovale: a 
higher proportion of P. ovale-infected RBCs adopt a 
clear oval shape, whereas those infected by P. vivax dis-
play a distorted shape (Fig. 2e–j, m, o). The presence of 
infected RBCs with fimbriated edges, which seems to 
be linked to the smearing conditions, is indicative of P. 
ovale (Fig. 1a–c, f ) where it occurs more frequently, but 
it can be observed for P. vivax. A detailed analysis of the 
changes in the outline of the infected RBCs can be found 
elsewhere [47].
Fig. 2 Microphotographs of Plasmodium vivax in Giemsa‑stained thin blood films collected in Singapore. a, b ring stages, c–e young trophozoites, 
f–h amoeboid trophozoites, i young schizont, j–l growing schizonts, m developed schizont, n mature schizont, o young gametocyte, p macroga‑
metocyte, r, q microgametocytes
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In both P. ovale and P. vivax, the Schüffner dots are a 
good differential characteristic because in P. ovale the 
stippling appears and then covers the entire parasitized 
cell in the early stages (from young rings, Fig.  1a–d), 
while in P. vivax is appears later as the trophozoites 
develop (Fig.  2e–h). In addition, the stippling is often 
more pronounced than that observed in P. vivax and the 
dots are usually bigger, regular in size, red to violet in col-
our, and tend to darken the RBC.
Another element to consider is the parasite’s nucleus. 
In the P. ovale trophozoite (Fig. 1g), the nucleus is almost 
double the size of that observed in P. vivax at the equiva-
lent stage (Fig.  2e–h), even though the P. ovale parasite 
is smaller in size. Furthermore, following the first steps 
of schizogony, the patches of chromatin are bigger in 
P. ovale than those produced in a young P. vivax schiz-
ont. In the mature schizont, the number of merozoites 
produced by P. ovale is usually eight (range from 4–16) 
(Fig. 1m) while P. vivax mature schizonts usually contain 
16 merozoites (range 16–24) (Fig. 2n).
The gametocytes of P. ovale (Fig.  1o–r) are smaller in 
size than those of P. vivax, their cytoplasm has a lighter 
purple-blue to pink stain, and their pigment is less abun-
dant than that of P. vivax (Fig. 2o–r).
While there are clear features that allow the distinction 
of P. ovale from P. vivax as presented above, we have not 
observed any morphological differences between P. ovale 
curtisi and P. ovale wallikeri by morphology.
Molecular characterization of Plasmodium ovale from the 
cases imported in Singapore
In order to characterize the P. ovale parasites from the 
11 cases imported in Singapore, genetic polymorphisms 
were sought on ten different loci spread across the three 
genomes of the parasites.
Nuclear genes
ssrRNA
This gene has long been used as a target for Plasmodium 
species identification, and the polymorphisms observed 
in this gene provided the first indication that P. ovale 
populations could be divided into ‘classical’ and ‘variant’ 
types. The sequences of the fragments (ca. 826 bp) ampli-
fied from the P. ovale samples from Singapore were com-
pared (Fig.  3a; GenBank accession numbers KP050361 
to KP050371) to those previously published [22, 23, 25, 
48]. The parasites from eight samples were P. o. curtisi 
(Po 2003, Po 2012-1, Po 2012-2, Po 2012-4, Po 2013-1, Po 
2013-2, Po 2013-3, and Po 2014-1), and the other three 
were P. o. wallikeri (Po 2006, Po 2012-3 and Po 2014-2). 
There was a higher diversity in the point mutations found 
for the P. o. wallikeri sequences, but the number of sam-
ples was too low to allow any meaningful conclusion.
Porbp2
The fragment (ca. 793  bp) analysed has been used pre-
viously to discriminate P. o. wallikeri from P. o. curtisi 
[23–25]. The sequences obtained for the 11 imported 
cases (Fig.  3b; GenBank accession numbers KP050394 
to KP050404) fully concord with those published to date, 
and confirmed the species identification obtained using 
the ssrRNA locus.
Pog3p
The fragment (ca. 662  bp) analysed has been used pre-
viously to discriminate P. o. wallikeri from P. o. curtisi 
[23]. The sequences obtained for the 11 imported cases 
(Fig.  3c; GenBank accession numbers KP050383 to 
KP050393) fully concord with those published to data, 
and confirmed the species identification obtained using 
the ssrRNA locus.
Potra
The fragment of variable size (from 293 to 347 bp) that 
was analysed has been used previously to discriminate 
P. o. wallikeri from P. o. curtisi [23, 24, 49]. Comparison 
of the predicted amino acid sequences obtained for the 
11 imported cases (Fig.  4a; GenBank accession num-
bers KP050372 to KP050382) confirmed the species 
identification obtained using the other loci. Further-
more, it showed that Po 2003, Po 2012-1, Po 2012-4, Po 
2013-2, and Po 2014-1 are similar to P. o. curtisi type 1 
[HM594182], while Po 2012-2, Po 2013-1 and Po 2013-3 
are similar to P. o. curtisi type 2 [HM594183] which 
is distinguished by two 6-amino acid (PISTIT) repeat 
units [23, 24]. Two of the three P. o. wallikeri sequences 
showed novel genotypes differing from previously pub-
lished genotypes by the size of the repeat units (Pow type 
1 [HM594180] and type 2 [HM594181]).
dhfr‑ts
Non-synonymous mutations and differences in the 
number of amino acid repeat units have been reported 
for the dhfr-ts of P. o. curtisi and P. o. wallikeri [23, 50]. 
Comparison of the complete gene sequences for the 
imported cases (GenBank accession numbers KP050405 
to KP050415) with those published (Fig.  4b), confirmed 
the classification into two groups of eight P. o. curtisi and 
three P. o. wallikeri sequences, although some additional 
non-synonymous mutations were observed.
asl
This gene encodes the housekeeping protein adenylosuc-
cinate lyase, an enzyme that is responsible for the salvage 
of host purines that are the used for DNA synthesis by 
Plasmodium [51]. The value of asl for phylogenetic and 
evolutionary studies of Plasmodium parasites has been 
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Fig. 3 Dimorphic nature of Plasmodium ovale curtisi and Plasmodium ovale wallikeri based on the partial sequences from three nuclear and two 
mitochondrial genes. a 18S ssrRNA, b Porbp2, c Pog3p, d cox1, e cytb genes. Each alignment includes sequences from the P. ovale cases imported in 
Singapore (highlighted in grey) and from published sequences. Numbering is based for the 18S ssrRNA gene on the asexually expressed (A type) 
gene [L48987], for the Porbp2 and Pog3p genes on the putative start‑codons (ATG) identified by [23], for the cox1 gene on the homologous position 
of the P. falciparum cox1 gene [M76611], and for the cytb gene on the start‑codon (ATG). For 18S ssrRNA gene the sets of sequences A1 and A2 con‑
tain: [L48986, L48987, AB182489, GQ231515, GQ183065, GQ183068] and [GU813972, JF894422, JF894425, JF894426] respectively; for Porbp2 gene 
the sets of sequences B1 and B2 contain: [GU813972, JF894422, JF894425, JF894426] and [GU813971, JF894427‑JF894429] respectively; for cytb 
gene the sets of sequences E1 to E4 gene contain [HQ712053, GQ231518‑GQ231520], [GU723535‑GU723537, GU723539‑GU723548], [HQ712052, 
AB354571, GQ231516‑GQ231517] and [AB182496, AF069625, GU723514‑GU723534], respectively. The Singapore P. o. wallikeri and Singapore P. o. 
curtisi sets represent for each gene the sequences obtained from [Po 2006, Po 2012‑3 and Po‑2014‑2] and from [Po 2003, Po 2012‑1, Po 2012‑2, Po 
2012‑4, Po 2013‑1, Po 2013‑2, Po 2013‑3 and Po‑2014‑1], respectively. Non‑synonymous mutations are in boldface type, hyphens represent gaps, dots 
represent nucleic acid identity and blanks represent unavailable information
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noted previously [52–54]. Amplification of asl was carried 
out for the 11 P. ovale samples as well as for P. vivax, P. fal-
ciparum, P. malariae, and P. knowlesi samples from cases 
recorded in Singapore. A 841-bp fragment was obtained 
for all the samples, and all the sequenced derived (Gen-
Bank accession numbers KP050460 to KP050474) were 
added to published ones for the phylogenetic analyses 
(Fig. 5). Sequences for this gene were not hitherto avail-
able in GenBank for P. ovale and P. malariae. A total of 62 
dimorphic loci have been identified between P. o. curtisi 
and P. o. wallikeri (Fig. 6). The number of dimorphic loci 
was higher than those recorded for the other genes stud-
ied in the present work. The two phylogenies obtained 
(Fig. 5) provided similar tree architecture, with all the P. 
ovale grouped within a biphyletic clade where P. o. curtisi 
and P. o. wallikeri are clearly separated.
Mitochondrial genes
cox1
This gene is commonly used for phylogenetic and evo-
lutionary studies, DNA bar-coding of metazoans, and to 
investigate P. o. curtisi and P. o. wallikeri [25, 26]. A 1,412-
bp fragment was amplified from each sample (GenBank 
accession numbers KP050416 to KP050426) and their 
sequences were compared to published ones (Fig.  3d). 
The sequences from the 11 imported P. ovale cases 
matched perfectly with those published for P. o. curtisi 
and P. o. wallikeri for all the 15 dimorphic loci.
cytb
This gene is also commonly used for phylogenetic and 
evolutionary studies, and it has been used to discriminate 
between the two P. ovale species [23, 26]. A 1244-bp frag-
ment was amplified from each of the imported P. ovale 
cases and their sequences (GenBank accession numbers 
KP050427 to KP050437) compared to those previously 
published (Fig. 3e), yielding the same conclusion as that 
from the cox1 gene above.
Apicoplast genes
Two conserved genes used for phylogenetic and evolu-
tionary studies belong to the third genome of the para-
site and are as yet uncharacterized for both the P. ovale 
species.
tufA
A single full P. ovale tufA sequence has been deposited in 
GenBank [AB649417] [55]. It originates from the Nige-
ria II strain that is classed as a P. o. curtisi, and has been 
compared to the sequences (GenBank accession numbers 
KP050449 to KP050459) of the 814-bp fragment ampli-
fied from each of the imported cases (Fig. 7a). A total of 
Fig. 4 Dimorphic nature of Plasmodium ovale curitsi and Plasmodium ovale wallikeri based on the translated amino acid sequences from two addi‑
tional nuclear genes. a Potra gene, and b dhfr‑ts gene. Each alignment includes sequences from the imported P. ovale cases imported in Singapore 
(highlighted in grey) and from published sequences. Dimorphic sites are in boldface type. For Potra gene, the distinction of between P. o. wallikeri 
types 1 and 2 is based on a two amino acid variation located outside of the amplified fragment presented here [24], and the distinction between 
P. o. curtisi types 1 and 2 is based on the number of PISTIT repeat (n = 1 or 2) [23, 24]. For dhfr‑ts gene, in addition to the dimorphisms between P. o. 
wallikeri and P. o. curtisi, the amino acid polymorphisms within each species are included to illustrate internal variations. In Potra gene for P. o. wallikeri 
the green and blue boxes represent the PINMAN repeats (n = 1–5) region and the PINAIT repeats (n = 2–4) region, respectively; for P. o. curtisi the 
orange box represents the PISTIT repeat (n = 1 or 2) region. In dhfr‑ts the red box represents the AT repeats (n = 1 or 2) region. Numbering is based 
on the ORF identified by [24] for Potra, and on the putative start‑codon (ATG) of dhfr‑ts. Hyphens represent gaps and dots represent amino acid 
identity
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Fig. 5 Combined phylogenetic trees generated by maximum likelihood (ML) (left part) and neighbour joining (NJ) (right part) methods using the 
partial sequences of the asl gene from different Plasmodium species. Of the sequences in the dataset, the 15 obtained in the present study are in 
boldface type (cases imported in Singapore: 8 P. o. curtisi (dark green box), 3 P. o. wallikeri (light green box), with 1 P. vivax, 1 P. falciparum, 1 P. knowlesi, 
and 1 P. malariae), the other 15 Plasmodium sequences (GenBank accession number is provided between vertical bars) from Plasmodium species 
that infect humans and primates (P. falciparum and Plasmodium reichenowi, red box; P. malariae, yellow box; Plasmodium fragile, Plasmodium simiovale, 
Plasmodium inui, Plasmodium cynomolgi, P. knowlesi and P. vivax, blue box), apes, rodents (Plasmodium yoelii, Plasmodium berghei, Plasmodium vinckei, 
and Plasmodium chabaudi, purple box) and birds (Plasmodium gallinaceum, orange box). The homologous fragment from the Toxoplasma gondii asl 
gene was used at the out‑group to root the trees. After alignment the sequences have been trimmed (≈800 bp) to adjust their size to the fragment 
with the most coverage
Fig. 6 Dimorphic nature of Plasmodium ovale curtisi and Plasmodium ovale wallikeri based on the partial sequences from the nuclear gene asl. The 
alignment highlights differences between P. o. curtisi on P. o. wallikeri at 62 loci. Numbering is based on the first nucleic acid of the forward oligonu‑
cleotide primer. Non‑synonymous mutations are in boldface type, and dots represent nucleic acid identity
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19 dimorphic loci were found between P. o. curtisi and P. 
o. wallikeri.
clpC
Three clpC sequences are available for P. ovale in Gen-
Bank: the full sequence extracted from [AB649417] [55], 
a partial sequence [AY634623] [56], and a sequence 
[HQ842632] (Kaiser et al. unpublished) from a P. ovale-
like parasite detected in chimpanzee. These were com-
pared to the sequences (GenBank accession numbers 
KP050438 to KP050448) of the 625-bp fragments ampli-
fied from the P. ovale imported cases (Fig. 7b). A total of 
15 dimorphic loci were found between P. o. curtisi and 
P. o. wallikeri. Sequences [AB649417] and [AY634623] 
matched the P. o. curtisi parasites. However, for sequence 
[HQ842632], the variations were more diverse: of the 15 
dimorphic loci, nine were similar to those of P. o. curtisi, 
four to those of P. o. wallikeri, and the remaining two 
loci differed from those previously noted for P. o. curtisi 
and P. o. wallikeri. Eleven additional mutations, three of 
which were non-synonymous, not previously observed in 
either P. o. curtisi and P. o. wallikeri, were also noted.
Discussion
The microscopic morphology of the parasite in stained 
blood smears is still considered to be the gold standard 
for the identification of Plasmodium species, and it is 
often the only technique available in clinical laboratories. 
However, the subtle morphological characteristics that 
help distinguish P. vivax and P. ovale are readily missed 
by less experienced microscopists, and might even elude 
expert microscopists who only encounter one or other 
of these two species infrequently or when the quality of 
the smears or the staining are sub-optimal [15, 38, 57]. 
Thus, it was not surprising that all the confirmed P. ovale 
cases in Singapore had been misidentified at P. vivax by 
the hospital laboratory staff that encounter Plasmodium 
parasites relatively infrequently. Current rapid diagnostic 
Fig. 7 Dimorphic nature of Plasmodium ovale curtisi and Plasmodium ovale wallikeri based on the partial sequences from two apicoplast genes. 
a tufA gene, and b clpC gene. Each alignment includes the sequences from the P. ovale cases imported in Singapore (highlighted in grey) and 
published sequences. The Plasmodium ovale‑like sequence [HQ842632] isolated from chimpanzee (Kaiser et al. unpublished) is included into this 
comparison but separated from P. o. curtisi and P. o wallikeri because it present 11 additional unique polymorphic loci beside the 15 dimorphic loci 
that distinguish P. o. curtisi and P. o wallikeri. Numbering is based on the start‑codon (ATG) identified for both tufA and clpC. Non‑synonymous muta‑
tions are in boldface type and dots represent nucleic acid similarity
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tests (RDTs) are inadequate for the direct identification 
of P. ovale [58] although some might be helpful in pre-
venting confusion with P. vivax [59]. Accurate diagnosis 
of P. ovale remains dependent on the use of molecular 
techniques such as PCR. However, even the reliable and 
well-adopted protocols [39] used in the present study has 
been shown to miss certain P. ovale cases [60]. To pre-
vent the risk of overlooking P. ovale, especially in mixed 
infection with others malaria species one might consider 
to choose a more sensitive protocol [60, 61]. It should be 
noted that the misidentification of P. ovale as P. vivax, or 
vice versa, has little clinical consequence because the rec-
ommended treatment for both species is the same [62].
The imported P. ovale cases uncovered in this study 
were genetically characterized for markers (ssrRNA, 
Potra, Porbp2, Pog3p, dhfr-ts, cytb, cox1) used in other 
recent studies [23–26]. The data were concordant with 
those previously obtained and allowed them to be clearly 
identified as P. o. curtisi or as P. o. wallikeri. For the ssr-
RNA, dhfr-ts and Potra genes, synonymous and non-
synonymous polymorphisms were noted within the 
sequences obtained for the P. o. curtisi or the P. o. wallik-
eri samples. These variations were broadly more numer-
ous for the P. o. wallikeri sequences; however, a higher 
number of samples will be required to confirm this trend. 
These observations indicate that ‘sub-types’ of P. o. curtisi 
and P. o. wallikeri might occur [23, 24, 26, 50, 63, 64] in 
humans and in chimpanzees. Analysis of a larger number 
of samples from humans and chimpanzees will be needed 
to test the hypothesis that a ‘P. ovale species complex’ is 
shared between humans and apes.
In the present study the genetic characterization was 
extended to three other genes that proved to be dimor-
phic between the two P. ovale species. The nuclear asl 
gene (encoding adenylosuccinate lyase) had the highest 
number of dimorphic loci in comparison with the other 
genes analysed, and displayed no internal variations 
within either the Poc or the Pow samples. These observa-
tions are consistent with the notion that P. o. curtisi and 
P. o. wallikeri have been evolving separately over a long 
period of time [23]. The other two genes analysed (tufA 
and clpC) are present on the apicoplast, whose genome 
has only been previously characterized for the Nige-
ria II P. ovale isolate [56]. A phylogenetic analysis of the 
asl fragments built from the 15 sequences obtained in 
this study from cases imported into Singapore and from 
other sequences from various P. ovale and other Plasmo-
dium species (downloaded from GenBank) that infect 
humans, apes, non-human primates, rodents, and birds 
showed that both P. ovale species cluster into a biphy-
letic clade that is related to other Plasmodium species 
of primates. This observation, based on a single nuclear 
gene, was congruent with the conclusions derived from 
analyses of the mitochondrial genome [26, 65, 66], but 
they did not support the recent suggestion, based on the 
analyses of the apicoplast genome, that P. ovale is closely 
related to the Plasmodium species of African rodents 
[56]. It also emphasizes that it would be desirable to 
adopt an approach based on multiple genes across sev-
eral genomes, using a larger number of samples for each 
species, in order to increase the likelihood of deriving a 
true phylogenetic relationship between the various Plas-
modium species [45].
All the confirmed P. ovale cases discovered in Singa-
pore were imported from endemic areas for this species 
[12] from eight countries (six in Africa and two in South 
and Southeast Asia) where this parasite has been previ-
ously recorded: Nigeria [67], Central African Republic 
[68], Uganda [10, 69], Ivory Coast [70], Cameroon [71], 
Equatorial Guinea [72], Liberia [6], India [72, 73], and 
Indonesia [74, 75]. The one case imported from India is 
interesting in that although P. ovale was first reported 
in this country 75  years ago, albeit as a doubtful mixed 
infection with P. falciparum [72], it has been reported 
since only five times [73, 76–79]. It is not at present clear 
whether this suggests that this parasite species is on the 
increase in India or whether its prevalence has been 
grossly underestimated through misidentification as P. 
vivax. The case imported from Indonesia is equally inter-
esting in that the patient had probably acquired the infec-
tion in Sumatra where P. ovale had not previously been 
recorded [5, 75].
Plasmodium vivax is consistently the species most fre-
quently imported in Singapore (70  %, 1512 of the 2155 
cases recorded between 2001 and 2014). Until the present 
study P. ovale infections had not been officially reported 
in Singapore, although a suspected diagnosis was made 
on two occasions in 1998 and in 2013 but not confirmed 
by MRC. For the period 2009–2011, molecular analysis 
of the 511 malaria-positive samples (386 identified as P. 
vivax by morphology) did not reveal any P. ovale infec-
tions, whereas nine P. ovale infections (four in 2012, three 
in 2013 and two in 2014) were detected from all the cases 
recorded in the last three years (316 cases with 238 iden-
tified as P. vivax by morphology in 2012–2014). For the 
period 2001–2008, a total of 1328 malaria-positive cases 
(888 identified as P. vivax by morphology) were notified 
to MOH, but only 226 frozen blood samples were avail-
able from this period (150 were identified as P. vivax 
by morphology) for molecular testing, revealing that 
two were actually P. ovale (one in 2003 and another in 
2006). If one assumes the same proportion of misiden-
tified P. ovale for the remaining 1,102 samples, then the 
expected total number of potential P. ovale cases for the 
2001–2011 period would be 12 out of the 1,835 recorded 
cases. Thus, it is possible that there has been a sharp 
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increase in the proportion of P. ovale recently imported 
to Singapore (an estimated 0.65 % for 2001–2011 versus 
2.85 % for 2012–2014). Such an increase would be puz-
zling given the constant decrease in the total number of 
malaria cases recorded in Singapore since 2010 [80]. This 
pattern does not seem to be restricted to Singapore, with 
similar, recent reports of P. ovale in imported malaria 
cases among soldiers deployed in endemic areas [16, 81], 
tourists visiting endemic countries [82, 83], and foreign 
workers returning from endemic regions [84–86]. Several 
hypotheses, alone or in combination, might be for formu-
lated to explain such an increase: (1) an upsurge of stud-
ies employing molecular tools that allow sensitive and 
accurate detection and identification of Plasmodium spe-
cies (this would not apply to the cases imported to Sin-
gapore over the last 6 years, because all were molecularly 
tested); (2) an increase over recent years in the number of 
travellers, visitors or migrant workers to P. ovale-endemic 
countries; and, (3) a recent increase in the prevalence 
of P. ovale in the endemic areas, possibly as a result of 
extensive campaigns directed against P. falciparum that 
might favour this less common species as suggested by 
[15] or as observed with the recent increase of P. knowlesi 
in Malaysia [87].
Public health concern in Singapore
Plasmodium ovale can induce relapses that can occur a 
long time after the primary infection and over several 
years [5, 9, 88]. Six of the nine imported cases to Singa-
pore in recent years were clearly due to relapsing P. ovale 
that had been acquired a few months to 4  years previ-
ously. Given the presence of competent mosquito vec-
tors such as Anopheles maculatus in Singapore [89] and 
the possibility of relapse episodes long after the primary 
infection [5, 9, 88] some of which are potentially asymp-
tomatic, clinicians, epidemiologists, laboratory techni-
cians, and public health officials should place P. ovale on 
a par with P. vivax as a potential threat to malaria elimi-
nation programmes [31, 82, 90, 91].
Conclusion
Routine malaria surveillance, incorporating molecular 
species determination performed by the MRC-NPHL, 
detected nine P. ovale infections that had been misiden-
tified in clinical laboratories settings as P. vivax among 
malaria cases imported to Singapore over the last 3 years. 
This is the first confirmed report of P. ovale in Singapore. 
Retrospective study on archived blood samples identi-
fied two additional misidentified P. ovale infections: one 
in 2003 and another in 2006. Both P. o. curtisi and P. o. 
wallikeri were found among the cases imported to Sin-
gapore, and their genetic dimorphism was confirmed 
using ten markers spread across the parasites’ three 
genomes (seven previously analysed in other studies and 
three additional ones that were not characterized before). 
The data suggest that there might have been an appar-
ent increase in the proportion of imported P. ovale in the 
face of a decrease in the overall number of malaria cases 
recorded in Singapore. Given its ability to cause relapses, 
P. ovale should not be neglected as a public health 
concern.
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